Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at Barclays Global Healthcare Conference Transcript

Mar 13, 2024 / 12:00PM GMT
Release Date Price: $48.25 (-0.31%)
Emily Field
Barclays Bank PLC, Research Division - Head of European Pharmaceuticals Equity Research

Okay. Good morning, everybody. Thanks for joining Day 2 of Barclays Global Healthcare Conference here in Miami. My name is Emily Field. I lead the European equity research team covering European pharmaceuticals out of London. And we're pleased to be joined today by the leaders of Sanofi's immunology team, Shaju Backer, who is the Global Head of the Immunology franchise; and Naimish Patel, who Heads Development for Immunology and Inflammation.

So as we were just getting started here, we thought maybe a good place to start was big therapeutic conference over the weekend, AAD. So I don't know if maybe that would be a good place to start because I know you guys presented a lot of data there. And then we can get into Q&A.

Shaju Backer;Naimish Patel
Sanofi - Global Head of Immunology Franchise;Sanofi - Head of Global Development,

Sure. Naimish, would you like to kick off with the amlitelimab data we presented at AAD?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot